Table 2. Primary Outcome Data.
| Study | Primary Outcome | Lower Dose Mortality | Higher Dose Mortality | Risk Ratio |
|---|---|---|---|---|
| Ronco et al(2000) 13 | Mortality at 15 days after stopping CVVH | 59% | 42.5% | 0.72 |
| Bouman et al (2002)15 | Mortality at 28 days after inclusion | 28.1% | 25.7% | 0.91 |
| Saudan et al (2006)16 | Mortality at 28 and 90 days | 61% | 41% | 0.67 |
| Tolwani et al (2008)17 | Mortality at 30 days or survival to ICU discharge | 44% | 51% | 1.16 |
| Bellomo et al (2009)19 | Mortality at 90 days after randomization | 44.7% | 44.7% | 1.00 |
| Schiffl et al (2002)14 | Mortality at 14 days after las hemodialysis | t 46% | 28% | 0.61 |
| Faulhaber-Walter et al (2009)20 | Mortality at 14 days after initiation of dialysis | 29.3% | 29.6% | 1.01 |
| Palevsky et al (2008)18 | Mortality at 60 days after randomization | 51.5% | 53.6% | 1.04 |
|
| ||||
| Summary | 0.89 | |||
Abbreviations: CVVH, continuous veno-venous hemofiltration; ICU, intensive care unit